Quizartinib
About
Therapy type: Targeted therapy
Therapy strategy: FLT3 inhibition
Mappings
NCI Thesaurus: Quizartinib (coding:ncit:C68936)
RxNorm: quizartinib (coding:rxcui:2643048, coding:omop:746225)
Therapeutic response
Precision oncology relationships for therapeutic response involving this therapy.
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| FDA (1) | FLT3-ITD | Acute Myeloid Leukemia | Quizartinib | |
| FDA (1) | FLT3-ITD | Acute Myeloid Leukemia | Cytarabine, Daunorubicin, Quizartinib | |
| FDA (1) | FLT3-ITD | Acute Myeloid Leukemia | Cytarabine, Idarubicin, Quizartinib |